The CobT enzyme of Salmonella typhimurium was shown in vitro to have NAD + -dependent ADPribosyltransferase activity. The CobT enzyme transferred the ADPribosyl moiety of NAD + onto 5,6-dimethylbenzimidazole (DMB) yielding a new dinucleotide, namely a-5,6-dimethylbenzimidazole adenine dinucleotide (a-DAD), whose identity was established by mass spectrometry. The N 1 -(a-D-ribosyl)-5,6-dimethylbenzimidazoyl moiety (a-ribazole) of a-DAD was incorporated into adenosylcobalamin (AdoCbl) by cell-free extracts of S. typhimurium, indicating that a-DAD served as an intermediate of AdoCbl biosynthesis. The rate of transfer of the ADPribosyl moiety was slower than the rate of transfer of the phosphoribosyl moiety of nicotinate mononucleotide (NaMN) to DMB. The CobT enzyme displayed a low K m for NaMN (0?51 mM) relative to the one for NAD + (9 mM); nicotinate adenine dinucleotide (NaAD) and nicotinamide mononucleotide (NMN) also served as substrates for CobT. In spite of the high K m of CobT for NAD + , the latter is proposed to be a relevant physiological substrate of CobT, given that the intracellular concentrations of NaMN, NMN and NaAD in actively growing S. typhimurium are undetectable. Evidence shows that extracts of S. typhimurium contain an as-yet unidentified dinucleotide pyrophosphatase that can cleave a-DAD into a-ribazole-59-P and AMP; a-ribazole-59-P can then enter the AdoCbl biosynthetic pathway.
INTRODUCTION
The late steps in adenosylcobalamin (AdoCbl) biosynthesis are referred to as the nucleotide loop assembly (NLA) pathway. Fig. 1 shows our current understanding of how the nucleotide loop of AdoCbl is assembled in Salmonella typhimurium. Genetic and biochemical evidence indicate that during de novo synthesis of AdoCbl, enzymes of the NLA pathway convert adenosylcobinamide phosphate (AdoCbi-P) to AdoCbi-GDP (catalysed by the CobU enzyme), activate the lower ligand base 5,6-dimethylbenzimidazole (DMB) to its nucleoside in two steps (catalysed by CobT and CobC), and join AdoCbi-GDP and N 1 -(a-D-ribosyl)-5,6-dimethylbenzimidazole (a-ribazole) to yield AdoCbl with the release of GMP as byproduct (catalysed by CobS) (Maggio-Hall & Escalante-Semerena, 1999; Warren et al., 2002) . The first step in the activation of DMB is catalysed by the CobT enzyme, whose well-documented nicotinate mononucleotide (NaMN)-dependent phosphoribosyltransferase activity yields N 1 -(5-phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole (a-ribazole-59-P); a-ribazole-59-P features a N-glycosidic bond in the a, rather than the more common b, configuration (Cheong et al., 1999 (Cheong et al., , 2001 (Cheong et al., , 2002 Friedmann & Harris, 1965; Trzebiatowski & Escalante-Semerena, 1997) . The second step in DMB activation is catalysed by the CobC enzyme, whose phosphatase activity dephosphorylates aribazole-59-P to yield a-ribazole . Fig. 1 also shows (broken arrows) the uncertainty that exists about the timing of the loss of the phosphate group modifying the 59 OH group of the ribosyl moiety of cobalamin. The alternative route for the removal of the 59 phosphate group of the ribosyl moiety shown in Fig. 1 is based on previously reported biochemical data (MaggioHall & Escalante-Semerena, 1999) .
Phenotypic analysis of cobT mutant strains of S. typhimurium revealed the unexpected phenotype of being able to synthesize AdoCbl if the medium was supplemented with DMB . This observation led to the proposal of the existence in S. typhimurium of an alternative activity that could compensate for the lack of CobT enzyme in cobT mutant strains (Trzebiatowski & Escalante-Semerena, 1997) . The requirement for DMB was interpreted to mean that the alternative function had a higher K m for DMB, thus the medium had to be supplemented with DMB. The alternative activity was subsequently shown to be encoded Abbreviations: AdoCbi, adenosylcobinamide; AdoCbl, adenosylcobalamin; a.m.u., atomic mass unit; a-DAD, a-5,6-dimethylbenzimidazole adenine dinucleotide; DMB, 5,6-dimethylbenzimidazole; ESIMS, electrospray ionization mass spectrometry; NaAD, nicotinate adenine dinucleotide; NaMN, nicotinate mononucleotide; NLA, nucleotide loop assembly; NMN, nicotinamide mononucleotide; -P, phosphate; a-ribazole, N by the cobB gene and as expected, cobT cobB double mutant strains were no longer responsive to exogenous DMB (Tsang & Escalante-Semerena, 1998) . The CobB protein was identified as a member of the Sir2 family of eukaryotic regulatory proteins (sirtuins) involved in gene silencing and cell ageing (Brachmann et al., 1995; Lin et al., 2000; Rine & Herskowitz, 1987; Tsang & Escalante-Semerena, 1998 (Frye, 1999; Tanny et al., 1999) and NAD + -dependent protein deacetylase activity (Imai et al., 2000; Smith et al., 2000; Starai et al., 2002; Tanner et al., 2000) . Relevant to the work presented in this paper is the ADPribosyltransferase activity of the CobB enzyme.
The CobT reaction yields a-ribazole-59-P when the enzyme transfers the phosphoribosyl moiety of NaMN to DMB (Trzebiatowski & Escalante-Semerena, 1997) . Data reported here show that CobT can transfer the ADPribosyl moiety of NAD + to DMB to yield a-5,6-dimethylbenzimidazole adenine dinucleotide (hereafter referred to as a-DAD) (Fig. 2) . A recent report showed that the Escherichia coli CobB protein used NAD + as substrate to derivatize DMB. The same report showed that the same activity was associated with the CobT protein from this bacterium (Frye, 1999) . The identity of the products of these reactions was not established.
We report here the purification and characterization of the product obtained when dinucleotides [NAD + or nicotinate adenine dinucleotide (NaAD)] were used as substrates for the CobT enzyme. This work shows that a-DAD can be used in vitro as substrate for enzymic conversion of adenosylcobinamide (AdoCbi) to AdoCbl. ) in a final volume of 20 ml. Initial velocity of the reactions was measured in reaction mixtures containing NMN or NaAD (1, 5 or 10 mM), or NaMN (0?25, 0?5, 1, 5 or 10 mM) and 0?012 mg purified CobT protein in a 20 ml final volume (Trzebiatowski & Escalante-Semerena, 1997) . The concentration of CobT in the mixture was increased 10-fold (0?12 mg) when NAD + (1, 5, 10, 20 or 40 mM) was used as substrate. To study these activities at physiological pH, assays were performed in 100 mM MOPS buffer, pH 7. Assays were incubated for 10 min (NaMN and NMN), 20 min (NaAD) or 90 min (NAD + ) at 37˚C and contained 80 mM [2- ); all assays were performed at least in duplicate. Quantification was performed after TLC (see below) using a PhosphorImager (Molecular Dynamics). Background was subtracted using controls that lacked phosphoribosyl or ADPribosyl moiety donors. Kinetic constants were derived from non-linear regression analysis of the NAD + and NaMN rate data using GraphPad Prism software (Intuitive Software for Science).
METHODS

In vitro enzyme activity assays
Nucleotide pyrophosphatase assays. A 50 ml reaction mixture containing 100 mM MOPS buffer pH 7, 2?5 mM MgCl 2 , 0?05 U snake venom nucleotide pyrophosphatase (Sigma) and purified a-DAD (200 mM) was incubated for 4 h at 37˚C. A reaction mixture without enzyme was used as negative control. Reaction mixtures were analysed by ion-exchange HPLC (see below).
In vitro NLA assays. NLA assays were performed at the 500 ml scale as described (Maggio-Hall & Escalante-Semerena, 1999 ) except that cell-free extracts were added simultaneously instead of sequentially. Where indicated, a-DAD (120 mM) substituted for NaMN and DMB in the reaction mixture. Plasmids pNLA1 (cobUST Tabor, 1990) were introduced into strain JE6200 [metE205 ara-9 D299(hisG-cobT) cobC1175 : : Tn10D16D17 pnuE : : MudQ]. Strain JE6200 was constructed by P22-mediated transduction of the pnuE : : MudQ allele from strain SF456 (pnuE : : MudQ) into strain JE2197 [metE205 ara-9 D299(hisG-cobT) cobC1175 : : Tn10d(Tc)] using previously described methods (Chan et al., 1972; Davis et al., 1980) . Reactions (final vol. 500 ml) were stopped by the addition of 100 ml 100 mM KCN followed by heating at 80˚C for 10 min to convert adenosylcorrinoids to cyanocorrinoids. Reaction mixtures were passed over C 18 SepPak columns (Waters), vacuumed to dryness in a SpeedVac concentrator (Savant Instruments), resuspended in 200 ml double-distilled water and analysed by reverse-phase HPLC (RP-HPLC) (see below).
Synthesis and purification of [2-
14 C]DMB. Radiolabelled [2-14 C]-DMB was synthesized as described (Trzebiatowski & EscalanteSemerena, 1997) .
Purification of NAD + . NAD + was resolved from ADPribose and NMN using a fast-flow DEAE anion-exchange resin (2?5640 cm; Toyopearl; Rohm & Haas) previously equilibrated with 10 mM NaCl at a flow rate of 250 ml h 21 ; a linear gradient from 10-300 mM NaCl resolved NAD + from the above-mentioned contaminants (Dickinson & Engel, 1977) . Fractions containing NAD + were identified by UV-visible spectroscopy, were concentrated under vacuum and applied onto a reverse-phase C 18 HPLC column to desalt NAD + (see below). The concentration of the purified product was determined using the molar extinction coefficient at 260 nm (e 260 ) of 17 600 M 21 (Dalziel & Dickinson, 1966) .
Synthesis and purification of a-DAD. A 5 ml CobT reaction mixture (pH 10) containing NaAD and 55 mg CobT protein was used to isolate microgram amounts of a-DAD. The incubation time was extended to 3 h, and a-DAD was isolated from the mixture by RP-HPLC followed by ion-exchange HPLC (see below); a-DAD was desalted by RP-HPLC and dried under vacuum.
Chromatographic techniques
TLC. Reagents and products of the CobT reaction were resolved using TLC as described (Maggio-Hall & Escalante-Semerena, 1999 ).
HPLC. a-DAD was isolated using a previously described RP-HPLC protocol (Maggio-Hall & Escalante-Semerena, 1999) . This procedure was also used to desalt a-DAD (retention time, 12?5 min) and NAD + (retention time, 10 min). Ion-exchange HPLC was performed on a Spheroclone SAX column (4?66250 mm; Phenomenex). The mobile phase was a 26 min gradient of potassium phosphate, pH 5?5 (40-500 mM). The column was developed at a flow rate of 1 ml min 21 . Under these conditions the retention time for a-DAD was 21 min. Cyanocorrinoids were resolved using a previously published RP-HPLC protocol (Blanche et al., 1990; O'Toole et al., 1993) . Samples (200 ml) were injected onto a Prodigy C 18 column (Phenomenex) equilibrated with a mobile phase containing 98 % solvent A (100 mM potassium phosphate buffer pH 8, containing 10 mM KCN), 1 % solvent B (100 mM potassium phosphate buffer pH 6?8, containing 10 mM KCN) and 1 % solvent C (acetonitrile). The column was developed with a 45 min linear gradient that changed the composition of the mobile phase to a 1 : 1 ratio of solvent B : solvent C. The column was equilibrated and developed at a rate of 1 ml min 21 .
Mass spectrometry. a-DAD and cyanocobalamin isolated from NLA reactions were subjected to electrospray ionization mass spectrometry (ESIMS) analysis at the Biotechnology Center at the University of Wisconsin-Madison.
RESULTS
NAD + or NaAD serve as substrate for the CobT enzyme
In vitro CobT activity assay mixtures containing DMB (80 mM) were performed using either NAD + or NaAD as co-substrates. TLC analysis of the reaction mixtures revealed a DMB derivative with a relative mobility (R F 0?44) that was clearly distinct from that of a-ribazole-59-P (R F 0?33). The specific activity of CobT with NaAD was 10-fold higher than the specific activity of the enzyme when NAD + was the substrate [35 vs 2?5 nmol min 21 (mg protein) 21 , respectively]. a-Ribazole-59-P was observed when either NaAD or NAD + was used as substrate due to small contaminating amounts of mononucleotide in the dinucleotide stocks. This contaminant was subsequently removed from the NAD + stock as described in Methods before determining the initial velocity measurements presented below. Fig. 3 shows the results of CobT reactions performed with NaMN (Fig. 3,  lane 1) or NaAD (Fig. 3, lane 2) . Under the conditions used, in both reactions nearly half of the substrate (~48 %) was converted to product.
The product of the CobT-catalysed reaction between DMB and NaAD is a-DAD A 5 ml reaction mixture containing NaAD and DMB was used to obtain product for spectroscopic analysis. After a 3 h incubation, the reaction mixture was analysed by HPLC (data not shown). Unreacted NaAD and DMB eluted at 8 min and 41 min, respectively. Nicotinate eluted with the void volume. A third compound eluted 13 min after injection, with a spectrum similar to that of NaAD, but with a slight shoulder at 280 nm (spectrum not shown). The product was collected and subjected to an additional purification step using ion-exchange HPLC to eliminate minor contaminants. The compound was dried down and subjected to ESIMS (Fig. 4) . The mass obtained, 686 atomic mass units (a.m.u.; M21), agreed with the predicted mass of a-DAD (687 a.m.u.). a-DAD can serve as the source of a-ribazole-59-P during in vitro assembly of the nucleotide loop of AdoCbl The nucleotide loop from AdoCbl was assembled in vitro using the protocol described in Methods. Functions of the CobU, CobS, CobT and CobC enzymes were confirmed by the results of a control experiment that used NaMN and DMB, AdoCbi and GTP as substrates (Fig. 5c ). HPLC and mass spectrometry data confirmed that when a-DAD substituted for DMB and NaMN in a reaction mixture containing CobU, CobT, CobS and CobC enzymes, the resulting adenosylcobamide was AdoCbl ( Fig. 5a ; HPLC, UV-visible spectroscopy, MS data not shown). When a similar experiment was performed in the absence of the CobC enzyme, AdoCbl-P was obtained (Fig. 5b) . The latter results suggested that a dinucleotide pyrophosphatase enzyme present in the extract cleaved a-DAD into a-ribazole-59-P and AMP, with the subsequent incorporation of a-ribazole-59-P into AdoCbl-P (Fig. 1) . It should be noted that the strains used to generate the CobUST-and CobC-enriched cell-free extracts were strains deficient in the periplasmic PnuE nucleotide pyrophosphatase. The absence of PnuE in the extract greatly reduced the background a-DAD cleaving activity (data not shown). Specific activities of CobT with mononucleotide (NaMN, NMN) or dinucleotide (NaAD, NAD + ) substrates Initial velocity measurements were performed to quantitatively compare the reactivity of CobT with NaAD and NAD + with those of the mononucleotides NaMN and NMN. CobT had higher specific activities with NaMN or NMN than with NaAD or NAD + , and in both cases the nicotinate forms were preferred over the nicotinamide derivative (data not shown). The apparent K m of the enzyme for NAD + was calculated to be 9?0 mM, the specific activity was 8?3 pmol min 21 (mg protein) 21 and the k cat was 0?62 min 21 . The kinetic parameters for NaMN were also determined at pH 7 to compare them with the NAD + parameters. For NaMN the apparent K m at pH 7 was found to be 0?51 mM, the specific activity was 2 083 pmol min 21 (mg protein) 21 and the k cat was 149 min 21 . These data (Table 1) show that under the conditions tested NaMN was the preferred substrate for the CobT enzyme.
DISCUSSION CobT has ADPribosyltransferase activity
The data presented here show that the CobT enzyme of S. typhimurium has ADPribosyltransferase activity in vitro, and that the product of this activity is a new dinucleotide, namely a-5,6-dimethylbenzimidazole adenine dinucleotide (a-DAD). The presence of the a-N-glycosidic bond in a-DAD was inferred from knowledge of the mechanism of the phosphoribosyltransferase reaction catalysed by CobT (Cheong et al., 1999 (Cheong et al., , 2001 (Cheong et al., , 2002 and from the results of the in vitro synthesis of AdoCbl-P by cell-free extracts lacking CobC phosphatase activity. Synthesis of AdoCbl-P from a-DAD and AdoCbi-GDP implies that an a-N-glycosidic bond was present in the ribazole-59-P derived from DAD, so the 39 OH of the ribosyl moiety of the ribazole-59-P could be coupled to AdoCbi-GDP by the CobS enzyme to yield the observed AdoCbl-P (Fig. 1) . Although it is clear that NaMN is the preferred substrate for the CobT enzyme, it cannot be ignored that the CobT enzyme can use NAD + as substrate (this work), that exponential-phase wild-type cells of Fig. 5 . Incorporation of a-DAD into AdoCbl by cell-free extracts of S. typhimurium. Shown are chromatograms of the RP-HPLC analysis of cyanocorrinoids. The degree of cyanation was not established, but the derivatization reaction was performed with excess cyanide over corrinoid to ensure full derivatization (Maggio-Hall & Escalante-Semerena, 1999) . In (a) and (b), a-DAD (120 mM) was added to the reaction mixture as the sole source of the a-ribazole moiety. (c) shows the analysis of a reaction mixture that contained NaMN and DMB in lieu of a-DAD (positive control). Reaction mixtures for the experiments shown in (a) and (c) contained cell-free extracts enriched for CobU, CobS, CobT and CobC proteins, so the anticipated reaction product was AdoCbl. The reaction mixture for the experiment shown in (b) contained cell-free extracts enriched for CobU, CobS and CobT, but not CobC. The accumulation of Cbl-P suggested a-DAD was cleaved by a dinucleotide pyrophosphatase. Peaks were identified by the retention time of standards and their UV-visible spectra. Cbi, dicyanocobinamide; Cbi-GDP, dicyanocobinamide-GDP; Cbl-P, cyanocobalamin-59-phosphate; Cbl, cyanocobalamin. S. typhimurium contain undetectable levels of NaMN, NMN and NaAD, and that the concentration of NAD + in exponential-phase cells is almost three orders of magnitude higher than any of these precursors (Bochner & Ames, 1982) .
The ability of the S. typhimurium CobT enzyme to use NAD + and its precursors NaMN, NMN and NaAD as substrates provides flexibility to the synthesis of AdoCbl under diverse physiological conditions
As mentioned above, the NAD + concentration in exponentialphase cells of S. typhimurium is several orders of magnitude higher than any of the above-mentioned NAD + precursors (790 mM vs undetectable) (Bochner & Ames, 1982) . This difference in the levels of NAD + and its abovementioned precursors would be enough to compensate for the 18-fold higher K m of CobT for NAD + than NaMN (0?51 mM) under physiological conditions of active growth. However, because the concentrations of NAD + precursors under other physiological conditions have not been measured, it is possible that the concentration of these precursors may rise under specific growth conditions. The ability of the CobT enzyme to use NaMN, NMN, NaAD or NAD + as substrates would allow S. typhimurium to synthesize a-ribazole-59-P for the assembly of AdoCbl under any growth conditions. We propose that both enzymic activities of the S. typhimurium CobT enzyme (phosphoribosyltransferase, ADPribosyltransferase) are physiologically relevant.
If NAD
+ is a physiological substrate for CobT in vivo, why does the CobT enzyme of S. typhimurium have a lower K m for NaMN?
The answer to this question may lie in the origin of the cob operon. It has been postulated that the entire cob operon (including cobT) was inherited by S. typhimurium from an unknown donor (Lawrence & Roth, 1996) . It is reasonable to speculate that the extant CobT enzyme might have evolved in a prokaryote whose intracellular level of NaMN was substantially higher than that found in S. typhimurium. Support for this idea can be found in studies of the CobT homologue of Propionibacterium fruendenreichii subsp. shermanii, which was reported to be unable to use NAD + as substrate (Friedmann, 1965) . The ability of the S. typhimurium CobT enzyme to use other NAD + precursors such as NMN as substrate is not shared by all CobT homologues, as reported for the CobT enzyme activity of Clostridium sticklandii which failed to use NMN as substrate (Fyfe & Friedmann, 1969) . The ability of the S. typhimurium CobT enzyme to use NAD + or its mononucleotide and dinucleotide precursors may be interpreted to mean that the physiological levels of these precursors may vary in this bacterium. Low levels of NAD + precursors may be the selective pressure for the evolution of CobT enzymes able to use NAD + as substrate.
Supporting in vivo evidence that NAD + is a substrate for the CobT enzyme in vivo
The ADPribosyltransferase activity of CobT is not likely to be an in vitro artefact. Recall that the CobB enzyme uses NAD + as substrate, that CobB has NAD + -dependent ADPribosyltransferase activity, that AdoCbl biosynthesis in cobT mutant strains of S. typhimurium is restored by the addition of DMB to the medium and that the response of cobT mutants to DMB depends on a functional CobB enzyme. Together, these facts strongly suggest that CobB transfers the ADPribose moiety of NAD + to DMB in vivo, resulting in the synthesis of a-DAD, effectively compensating for the lack of CobT enzyme (Fig. 6) . It is important, however, to keep in mind that the CobB enzyme is not part of the AdoCbl biosynthetic pathway; instead CobB function is critical for the post-translational regulation of acylcoenzyme A synthetase activities and probably of other members of the AMP-forming family of enzymes (Starai et al., 2002 (Starai et al., , 2003 . Under growth conditions that require low levels of AdoCbl (e.g. methionine synthesis), the ADPribosyltransferase activity of CobB fully compensates for the lack of CobT . However, under physiological conditions that require a higher level of the coenzyme (e.g. growth on ethanolamine or 1,2-propanediol as carbon and energy source), CobB does not compensate for the lack of CobT, suggesting that the Fig. 6 . Modified NLA pathway. In this model, the CobT enzyme acts as a NaMN-dependent phosphoribosyltransferase or a NAD + -dependent ADPribosyltransferase to yield a-ribazole-59-P. CobB is the S. typhimurium homologue of the eukaryotic Sir2 enzyme. Sir2-like enzymes, including CobB, have protein deacetylase and ADPribosyltransferase activities. CobB is proposed to catalyse the inefficient formation of a-DAD from NAD + and DMB. Cleavage of a-DAD by an as-yet unidentified glycohydrolase enzyme would generate a-ribazole, bypassing the need for CobC activity. Evidence reported in this paper supports the existence of a dinucleotide pyrophosphatase activity capable of hydrolysing a-DAD into AMP and a-ribazole-59-P. At present, no evidence for an a-ribazole-forming glycohydrolase activity has been obtained. Question marks represent unidentified enzymes. Genetic and biochemical evidence support the reactions represented by solid arrows. Only in vitro biochemical evidence supports the reactions represented by broken arrows.
